# Ameren Corp: financial statements, quarterly

AEE · NYSE · CIK 1002910 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aee.md) · [Financials](/companies/aee/financials.md) · [Filings](/companies/aee/filings.md) · [Insiders](/companies/aee/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aee/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,060](/filings/0001002910-24-000111.md) | [1,618 d](/filings/0001002910-26-000009.md) | [1,816](/filings/0001002910-25-000098.md) | [1,693](/filings/0001002910-25-000112.md) | [2,173](/filings/0001002910-25-000129.md) | [1,941 d](/filings/0001002910-26-000009.md) | [2,097](/filings/0001002910-26-000015.md) | [2,221](/filings/0001002910-26-000023.md) | [2,699](/filings/0001002910-25-000129.md) | [1,782 d](/filings/0001002910-26-000009.md) | [2,176](/filings/0001002910-26-000015.md) | [2,092](/filings/0001002910-26-000023.md) |
| Operating income | $m | [614](/filings/0001002910-24-000111.md) | [264 d](/filings/0001002910-26-000009.md) | [371](/filings/0001002910-25-000098.md) | [361](/filings/0001002910-25-000112.md) | [586](/filings/0001002910-25-000129.md) | [198 d](/filings/0001002910-26-000009.md) | [430](/filings/0001002910-26-000015.md) | [411](/filings/0001002910-26-000023.md) | [825](/filings/0001002910-25-000129.md) | [360 d](/filings/0001002910-26-000009.md) | [532](/filings/0001002910-26-000015.md) | [459](/filings/0001002910-26-000023.md) |
| Interest expense | $m | [152](/filings/0001002910-24-000111.md) | [153 d](/filings/0001002910-26-000009.md) | [154](/filings/0001002910-25-000098.md) | [165](/filings/0001002910-25-000112.md) | [173](/filings/0001002910-25-000129.md) | [171 d](/filings/0001002910-26-000009.md) | [175](/filings/0001002910-26-000015.md) | [187](/filings/0001002910-26-000023.md) | [208](/filings/0001002910-25-000129.md) | [206 d](/filings/0001002910-26-000009.md) | [204](/filings/0001002910-26-000015.md) | [209](/filings/0001002910-26-000023.md) |
| Income tax | $m | [69.0](/filings/0001002910-24-000111.md) | [39.0 d](/filings/0001002910-26-000009.md) | [44.0](/filings/0001002910-25-000098.md) | [39.0](/filings/0001002910-25-000112.md) | [57.0](/filings/0001002910-25-000129.md) | [(57.0) d](/filings/0001002910-26-000009.md) | [50.0](/filings/0001002910-26-000015.md) | [43.0](/filings/0001002910-26-000023.md) | [52.0](/filings/0001002910-25-000129.md) | [(9.0) d](/filings/0001002910-26-000009.md) | [60.0](/filings/0001002910-26-000015.md) | [52.0](/filings/0001002910-26-000023.md) |
| Net income | $m | [494](/filings/0001002910-24-000111.md) | [159 d](/filings/0001002910-26-000009.md) | [262](/filings/0001002910-25-000098.md) | [260](/filings/0001002910-25-000112.md) | [457](/filings/0001002910-25-000129.md) | [208 d](/filings/0001002910-26-000009.md) | [290](/filings/0001002910-26-000015.md) | [277](/filings/0001002910-26-000023.md) | [641](/filings/0001002910-25-000129.md) | [253 d](/filings/0001002910-26-000009.md) | [358](/filings/0001002910-26-000015.md) | [316](/filings/0001002910-26-000023.md) |
| Diluted EPS | $ per share | [1.87](/filings/0001002910-24-000111.md) | not reported | [0.98](/filings/0001002910-25-000098.md) | [0.97](/filings/0001002910-25-000112.md) | [1.70](/filings/0001002910-25-000129.md) | not reported | [1.07](/filings/0001002910-26-000015.md) | [1.01](/filings/0001002910-26-000023.md) | [2.35](/filings/0001002910-25-000129.md) | not reported | [1.28](/filings/0001002910-26-000015.md) | [1.13](/filings/0001002910-26-000023.md) |
| Basic EPS | $ per share | [1.88](/filings/0001002910-24-000111.md) | not reported | [0.98](/filings/0001002910-25-000098.md) | [0.97](/filings/0001002910-25-000112.md) | [1.71](/filings/0001002910-25-000129.md) | not reported | [1.07](/filings/0001002910-26-000015.md) | [1.02](/filings/0001002910-26-000023.md) | [2.37](/filings/0001002910-25-000129.md) | not reported | [1.29](/filings/0001002910-26-000015.md) | [1.14](/filings/0001002910-26-000023.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0001002910-23-000112.md) | [0.0](/filings/0001002910-25-000055.md) | [0.1](/filings/0001002910-24-000090.md) | [0.0](/filings/0001002910-24-000101.md) | [0.0](/filings/0001002910-24-000111.md) | [0.0](/filings/0001002910-26-000009.md) | [0.0](/filings/0001002910-25-000098.md) | [0.0](/filings/0001002910-25-000112.md) | [0.0](/filings/0001002910-25-000129.md) | [0.0](/filings/0001002910-26-000023.md) | [0.0](/filings/0001002910-26-000015.md) | [0.0](/filings/0001002910-26-000023.md) |
| Current assets | $bn | [2.1](/filings/0001002910-23-000112.md) | [2.2](/filings/0001002910-25-000055.md) | [2.1](/filings/0001002910-24-000090.md) | [2.2](/filings/0001002910-24-000101.md) | [2.3](/filings/0001002910-24-000111.md) | [2.3](/filings/0001002910-26-000009.md) | [2.5](/filings/0001002910-25-000098.md) | [2.5](/filings/0001002910-25-000112.md) | [2.6](/filings/0001002910-25-000129.md) | [2.6](/filings/0001002910-26-000023.md) | [2.6](/filings/0001002910-26-000015.md) | [2.6](/filings/0001002910-26-000023.md) |
| Total assets | $bn | [39.6](/filings/0001002910-23-000112.md) | [40.8](/filings/0001002910-25-000055.md) | [41.3](/filings/0001002910-24-000090.md) | [42.3](/filings/0001002910-24-000101.md) | [43.3](/filings/0001002910-24-000111.md) | [44.6](/filings/0001002910-26-000009.md) | [45.7](/filings/0001002910-25-000098.md) | [46.6](/filings/0001002910-25-000112.md) | [47.4](/filings/0001002910-25-000129.md) | [48.5](/filings/0001002910-26-000023.md) | [49.8](/filings/0001002910-26-000015.md) | [51.2](/filings/0001002910-26-000023.md) |
| Current liabilities | $bn | [4.0](/filings/0001002910-23-000112.md) | [3.3](/filings/0001002910-25-000055.md) | [3.5](/filings/0001002910-24-000090.md) | [3.3](/filings/0001002910-24-000101.md) | [3.6](/filings/0001002910-24-000111.md) | [3.4](/filings/0001002910-26-000009.md) | [2.9](/filings/0001002910-25-000098.md) | [3.1](/filings/0001002910-25-000112.md) | [2.8](/filings/0001002910-25-000129.md) | [3.9](/filings/0001002910-26-000023.md) | [4.1](/filings/0001002910-26-000015.md) | [5.0](/filings/0001002910-26-000023.md) |
| Long-term debt | $bn | [13.8](/filings/0001002910-23-000112.md) | [15.1](/filings/0001002910-25-000055.md) | [15.2](/filings/0001002910-24-000090.md) | [16.3](/filings/0001002910-24-000101.md) | [16.4](/filings/0001002910-24-000111.md) | [17.3](/filings/0001002910-26-000009.md) | [18.4](/filings/0001002910-25-000098.md) | [18.8](/filings/0001002910-25-000112.md) | [19.2](/filings/0001002910-25-000129.md) | [18.2](/filings/0001002910-26-000023.md) | [19.0](/filings/0001002910-26-000015.md) | [19.1](/filings/0001002910-26-000023.md) |
| Current portion of debt | $bn | [0.8](/filings/0001002910-23-000112.md) | [0.8](/filings/0001002910-25-000055.md) | [1.1](/filings/0001002910-24-000090.md) | [0.8](/filings/0001002910-24-000101.md) | [0.3](/filings/0001002910-24-000111.md) | [0.3](/filings/0001002910-26-000009.md) | [0.0](/filings/0001002910-25-000098.md) | [0.0](/filings/0001002910-25-000112.md) | [0.0](/filings/0001002910-25-000129.md) | [1.0](/filings/0001002910-26-000023.md) | [1.1](/filings/0001002910-26-000015.md) | [1.5](/filings/0001002910-26-000023.md) |
| Short-term borrowings | $bn | [1.3](/filings/0001002910-23-000112.md) | [0.5](/filings/0001002910-25-000055.md) | [0.9](/filings/0001002910-24-000090.md) | [0.7](/filings/0001002910-24-000101.md) | [1.5](/filings/0001002910-24-000111.md) | [1.1](/filings/0001002910-26-000009.md) | [1.3](/filings/0001002910-25-000098.md) | [1.1](/filings/0001002910-25-000112.md) | [0.9](/filings/0001002910-25-000129.md) | [0.6](/filings/0001002910-26-000023.md) | [1.2](/filings/0001002910-26-000015.md) | [1.2](/filings/0001002910-26-000023.md) |
| Shareholders' equity | $bn | [11.0](/filings/0001002910-23-000112.md) | [11.3](/filings/0001002910-25-000055.md) | [11.4](/filings/0001002910-24-000090.md) | [11.5](/filings/0001002910-24-000101.md) | [11.8](/filings/0001002910-24-000111.md) | [12.1](/filings/0001002910-26-000009.md) | [12.2](/filings/0001002910-25-000098.md) | [12.3](/filings/0001002910-25-000112.md) | [12.8](/filings/0001002910-25-000129.md) | [13.4](/filings/0001002910-26-000023.md) | [13.6](/filings/0001002910-26-000015.md) | [13.7](/filings/0001002910-26-000023.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [920 d](/filings/0001002910-24-000111.md) | [533 d](/filings/0001002910-26-000009.md) | [492](/filings/0001002910-25-000098.md) | [557 d](/filings/0001002910-25-000112.md) | [897 d](/filings/0001002910-25-000129.md) | [817 d](/filings/0001002910-26-000009.md) | [431](/filings/0001002910-26-000015.md) | [862 d](/filings/0001002910-26-000023.md) | [1,104 d](/filings/0001002910-25-000129.md) | [956 d](/filings/0001002910-26-000009.md) | [421](/filings/0001002910-26-000015.md) | [770 d](/filings/0001002910-26-000023.md) |
| Capital expenditure | $m | [749](/filings/0001002910-24-000111.md) | [1,026 d](/filings/0001002910-26-000009.md) | [890](/filings/0001002910-25-000098.md) | [1,002](/filings/0001002910-25-000112.md) | [1,137](/filings/0001002910-25-000129.md) | [1,290 d](/filings/0001002910-26-000009.md) | [1,064](/filings/0001002910-26-000015.md) | [1,066](/filings/0001002910-25-000112.md) | [988](/filings/0001002910-25-000129.md) | [1,010 d](/filings/0001002910-26-000009.md) | [1,574](/filings/0001002910-26-000015.md) | [1,079 d](/filings/0001002910-26-000023.md) |
| Dividends paid | $m | [166 d](/filings/0001002910-24-000111.md) | [166 d](/filings/0001002910-26-000009.md) | [178](/filings/0001002910-25-000098.md) | [178 d](/filings/0001002910-25-000112.md) | [179 d](/filings/0001002910-25-000129.md) | [179 d](/filings/0001002910-26-000009.md) | [191](/filings/0001002910-26-000015.md) | [193 d](/filings/0001002910-26-000023.md) | [192 d](/filings/0001002910-25-000129.md) | [192 d](/filings/0001002910-26-000009.md) | [208](/filings/0001002910-26-000015.md) | [206 d](/filings/0001002910-26-000023.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [260](/filings/0001002910-23-000112.md) | [263](/filings/0001002910-24-000090.md) | [263](/filings/0001002910-24-000101.md) | [263](/filings/0001002910-24-000111.md) | [267](/filings/0001002910-25-000098.md) | [267](/filings/0001002910-25-000112.md) | [267](/filings/0001002910-25-000129.md) | [271](/filings/0001002910-26-000015.md) | [272](/filings/0001002910-26-000023.md) | [272](/filings/0001002910-25-000129.md) | [278](/filings/0001002910-26-000015.md) | [279](/filings/0001002910-26-000023.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 276,843,251 at 2026-07-30, from the cover of the [10-Q filed 2026-08-03](/filings/0001002910-26-000023.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.